Buy & Sell FedEx Corporation (FDX) – FedEx Corporation Price Today
Key Stats
- $89.66BMarket Cap
- IndustrialsSector
- -12.03%3M Drawdown
- $123.68BEnterprise Value
- 1.54%Dividend Yield
- 91% Buy | 9% SellTrading Activity
- 82 daysTypical Hold Time
FedEx Corporation (FDX) is currently valued at a market capitalization of $89.66B, with an enterprise value of $123.68B. Over the past 52 weeks, FedEx Corporation has traded between a low of $216.61 and a high of $403.31, highlighting its annual price range. Over the past three months, FedEx Corporation has recorded a drawdown of -12.03%, reflecting recent price volatility. FedEx Corporation offers a dividend yield of 1.54%, with the most recent dividend of $1.45 paid on 09 Mar 26. On average, investors hold FedEx Corporation for approximately 82 days, indicating typical investor behavior on the platform.
About FedEx Corporation
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.
Most Recent News
Anthropic acquires Stainless to enhance developer tools and API connections for $300M.
Anthropic has acquired Stainless, a startup specializing in developer tools for APIs, for approximately $300 million. Stainless, founded in 2022, has worked with major clients including Google DeepMind, Meta, and OpenAI, and developed software linked...
Boston Scientific invests $1.5B for stake in MiRus, targeting advanced aortic stenosis treatment.
Boston Scientific has invested $1.5 billion to acquire about a 34% stake in MiRus, gaining exclusive rights to its investigational transcatheter aortic valve replacement (TAVR) system designed for severe aortic stenosis. The SIEGEL valve features a n...
Elliott sees hidden value in Bio-Rad via $5B Sartorius stake amid share price slump
Activist investor Elliott Investment Management has taken a significant stake in Bio-Rad Laboratories, which develops medical instruments and software. Bio-Rad's founding family retains majority voting control, complicating activist efforts. Elliott ...